J Danforth Quayle

Director Quayle sells 14,525 CVNA shares at $70.00 per 10b5-1 plan; retains 214,960 shares + 29,045 in options.

Director J Danforth Quayle sold 14,525 shares of CARVANA (CVNA) at $70.00 on 2026-06-10 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-11—a scheduled, non-discretionary transaction. Post-sale, Quayle retains 214,960 non-derivative shares plus 29,045 shares through stock options, representing a partial reduction of his non-derivative position of -6.3% rather than an exit. His prior trades at CVNA show a pattern of sales followed by negative 30-day and 90-day returns (ranging from -75.5% to -80.5%), though this particular transaction is governed by a pre-arranged schedule, not active discretion. The stock has declined 8.0% over the prior 30 days and 30.4% from its 52-week high of $97.38, while year-to-date fundamentals show strong revenue growth of +48.6% and a low P/E of 6.64, leaving a mixed signal on valuation trends.

Director Quayle J Danforth sells 11,614 shares of CVNA at $304.24 for $3.5M; holds 41,913 post-trade.

Danforth sold 11,614 shares (21.7% of his pre-transaction holdings) at $304.24 on 2025-05-14, reducing his stake to 41,913 shares. His prior five trades at CVNA were all sells executed on 2024-05-07 and 2024-05-08, with a consistent pattern: 90-day post-sale performance averaged between -75.5% and -77.9%, and all five prior trades achieved well-timed execution (5 of 5 at the 90-day mark). Across his cross-ticker open-market history, Danforth has completed 6 prior sells with an average 90-day return of -77.0% and a 100.00% well-timed rate. His current sale price of $304.24 is now -2.6% from the 52-week high of $61.10, positioning this transaction near the peak of the stock's range, consistent with his demonstrated historical pattern of selling before subsequent declines.